Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection;Associazione tra genotipo virale, HLA e manifestazioni extra-epatiche dell'epatite C

Reumatismo

Volumn 60, Issue 3, 2008, Pages 192-198

  Giannitti, Chiara ^a   Morozzi, G ^a   D'Alfonso, S ^b   Bellisai, F ^a   Galeazzi, M ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Extra hepatic manifestations; HCV HLA

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ2 ANTIGEN; HLA DQ3 ANTIGEN; HLA DR3 ANTIGEN; HLA DR6 ANTIGEN; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ALLELE; ARTICLE; ASSAY; AUTOIMMUNE THYROIDITIS; CARPAL TUNNEL SYNDROME; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ITALY; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; STATISTICAL ANALYSIS;

AGED; ARTHRITIS; CARPAL TUNNEL SYNDROME; CRYOGLOBULINEMIA; FEMALE; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HLA-D ANTIGENS; HUMANS; MALE; MIDDLE AGED; RHEUMATOID FACTOR; SJOGREN'S SYNDROME; THYROIDITIS, AUTOIMMUNE;

EID: 57149133438     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Mountz JD, Talal N. Retrovires, apoptosis and autoantigens. Immunology Today 1993; 14: 532-6.
2. Behar SM, Porcelli SA. Mechanisms of autoimmune disease induction, the role of the immune response to microbial pathogens. Arthritis Rheum 1995; 38: 458-76.
3. Pivetti S, Novarino A, Merico F, Bertero MT, Brunetto MR, Bonino F, et al. High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders. Br J Haematol 1996; 95: 204-11.
4. Buskila D. Hepatitis C-associated arthritis. Curr Opin Rheumatol 2000; 12: 295-9.
5. Mayo MJ. Extrahepatic manifestations of hepatitis C infection. Am J Med Sci 2003; 325: 135-48.
6. Lormeau C, Falgarone G, Roulot D, Boissier MC. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 2006; 73: 633-8.
7. Sterling RK, Bralow S. Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep 2006; 8: 53-9.
8. Vassilopoulos D, Calabrese LH. Extrahepatic immunological complications of hepatitis C virus infection. AIDS 2005; 19 (3 Suppl): 123S-7S.
9. Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 2006; 44: 15-22.
10. Durazzo M, Mariani GM, Sacchi C, Biava MA. HCV and extrahepatic diseases. Minerva Gastroenterol Dietol 1998; 44: 91-104.
11. Kristiansen MG,Florholmen J. Extrahepatic manifestations in hepatitis C. Are they overlooked? Tidsskr Nor Laegeforen 2001; 121: 446-9.
12. Nagao Y, Sata M, Itoh K, Tanikawa K, Kameyama T. Quantitative analysis of HCV- RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest 1996; 26: 495-8.
13. Lodi G, Carrozzo M, Hallet R, D'Amico E, Piattelli A, Teo CG, et al. HCV genotypes in Italian patients with HCV-related oral lichen planus. J Oral Pathol Med 1997; 26: 381-4.
14. Sebastiani GD, Galeazzi M, Morozzi G, Marcolongo R. The immunogenetics of the antiphospholipid syndrome, anticardiolipin antibodies and lupus anticoagulant. Semin Arthritis Rheum 1996; 25: 414-20.
15. Lulli P, Sebastiani GD, Trabace S, Passiu G, Cappellacci S, Porzio F, et al. HLA antigens in Italian patients with systemic lupus erythematosus: evidence for the association of DQw2 with the autoantibody response to extractable nuclear antigens. Clin Exp Rheumatol 1991; 9: 475-9.
16. Galeazzi M, Sebastiani GD, Tincani A, Piette JC, Allegri F, Morozzi G, et al. HLA class II associations of anti-cardiolipin and anti-beta2GPI antibodies in a large series of european patients with systemic lupus erythematosus. Lupus 2000; 9: 47-55.
17. Rendine S, Borelli I, Barbanti M, Sacchi N, Roggero S, Cartoni ES. HLA polymorphisms in Italian bone marrow donors: a regional analysis. Tissue Antigens 1998; 52: 135-46.
18. www.allelefrequencies.net
19. Sebastiani GD, Bellisai F, Caudai C, Rottoli P, Valensin PE, Pippi L, et al. Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients. J Biol Regul Homeost Agents 2005; 19: 17-22.
20. Yoon SK, Han JY, Pyo CW, Yang JM, Jang JW, Kim CW, et al. Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population. Liver Int 2005; 25: 1122-7.
21. Zavaglia C, Martinetti M, Silini E, Bottelli R, Daielli C, Asti M, et al. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol 1998; 28: 1-7.
22. Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol 1998; 29: 207-13.
23. Mangia A, Gentile R, Cascavilla I, Margaglione M, Villani MR, Stella F, et al. HLA class II favors clearance of HCV infection and progression of the chronic liver damage. J Hepatol 1999; 30: 984-9.
24. Minton EJ, Smillie D, Neal KR, Irving WL, Underwood JC, James V. Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group.J Infect Dis 1999; 179: 1309-10.
25. Alric L, Fort M, Izopet J, Vinel JP, Bureau C, Sandre K, et al. Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance. Tissue Antigens 2000; 56: 154-8.
26. De Re V, Caggiari L, Talamini R, Crovatto M, De Vita S, Mazzaro C, et al. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles. Hum Immunol 2004; 65: 1397-404.
27. Yee LJ. Host genetic determinants in hepatitis C virus infection. Genes Immun 2004; 5: 237-45.
28. Yoshizawa K, Ota M, Saito S, Maruyama A, Yamaura T, Rokuhara A, et al. Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease. Tissue Antigens 2003; 61: 159-65.
29. Alric L, Fort M, Izopet J, Vinel JP, Charlet JP, Selves J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997; 113: 1675-81.
30. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 1999 Dec 18-25; 354: 2119-24.
31. Tillmann HL, Chen DF, Trautwein C, Kliem V, Grundey A, Berning-Haag A, et al. Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease. Gut 2001; 48: 714-8.
32. Hong X, Yu RB, Sun NX, Wang B, Xu YC, Wu GL. Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis. World J Gastroenterol 2005; 11: 7302-7.
33. Harcourt G, Hellier S, Bunce M, Satsangi J, Collier J, Chapman R, et al. Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J Viral Hepat 2001; 8: 174-9.
34. Lechmann M, Schneider EM, Giers G, Kaiser R, Dumoulin FL, Sauerbruch T, et al. Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection. Eur J Clin Invest 1999; 29: 337-43.
35. McKiernan SM, Hagan R, Curry M, McDonald GS, Kelly A, Nolan N, et al. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 2004; 40: 108-14.
36. Carrozzo M, Francia Di Celle P, Gandolfo S, Carbone M, Conrotto D, Fasano ME, et al. Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated oral lichen planus. Br J Dermatol 2001; 144: 803-8.
37. Scotto G, Fazio V, D'Alessandro G, Monno L, Saracino A, Palombo E, et al. Association between HLA class II antigens and hepatitis C virus infection. J Biol Regul Homeost Agents 2003; 17: 316-21.
38. Amoroso A, Berrino M, Canale L, Cornaglia M, Guarrera S, Mazzola G, et al. Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection. J Hepatol 1998; 29: 36-44.
39. Congia M, Clemente MG, Dessi C, Cucca F, Mazzoleni AP, Frau F, et al. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology 1996; 24: 1338-41.
40. Cacoub P, Renou C, Kerr G, Hue S, Rosenthal E, Cohen P, et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 2001; 44: 2118-24.
41. Manns MP, Rambusch EG. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J Hepatol 1999; 31 (Suppl 1): 39-42.
42. Nocente R, Ceccanti M, Bertazzoni G, Cammarota G, Silveri NG, Gasbarrini G. HCV infection and extra-hepatic manifestations. Hepatogastroenterology 2003; 50: 1149-54.
43. Lenzi M, Frisoni M, Mantovani V, Ricci P, Muratori L, Francesconi R, et al. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 1998; 91: 2062-6.
44. Hwang SJ, Chu CW, Huang DF, Lan KH, Chang FY, Lee SD. Genetic predispositions for the presence of cryoglobulinemia and serum autoantibodies in Chinese patients with chronic hepatitis C. Tissue Antigens 2002; 59: 31-7.
45. Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31-4.
46. Ferri C, Zignego AL. Relation between infection and autoimmunity in mixed cryoglobulinemia. Curr Opin Rheumatol 2000; 12: 53-60.
47. Ghinoi A, Mascia MT, Puccini R, Ferri C. Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia. G Ital Nefrol 2004; 21: 225-37.
48. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 2000; 79: 47-56.
49. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Ghinoi A, Mascia MT, et al. Extrahepatic manifestations of hepatitis C virus: the thyroid disorders. Recenti Prog Med 2005; 96: 370-81.
50. Broussolle C, Steineur MP, Bailly F, Zoulim F, Trepo C. Hepatitis C virus infection and thyroid diseases. Rev Med Interne 1999; 20: 766-73.
51. Huang MJ, Tsai SL, Huang BY, Sheen IS, Yeh CT, Liaw YF. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study. Clin Endocrinol (Oxf)1999; 50: 503-9.
52. Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, et al. Thyroid disorders in chronic hepatitis C. Am J Med 2004; 117: 10-3.